Test Price
1,800 AED✅ Home Collection Available
Cryptococcus Antibody Test in UAE – 1800 AED – DHA Licensed Laboratory
Executive Summary & Core Metrics
This advanced serological assay detects host IgG/IgM antibodies against Cryptococcus neoformans using standardized latex agglutination with quantitative titration. Performed at an ISO 9001:2015 accredited reference laboratory, the test delivers diagnostic sensitivity exceeding 99.9% and serves as a complementary tool alongside cryptococcal antigen testing and cerebrospinal fluid analysis for patients presenting with neurological or respiratory symptoms suggestive of cryptococcal disease.
- ✔Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139). Standardized latex agglutination with quantitative titration performed at certified reference facilities.
- ✔Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy — available 8:00 AM to 11:00 PM across all Emirates, seven days a week.
- ✔Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by qualified clinical coordinators familiar with cryptococcal disease management protocols.
- ✔Insurance: Direct Billing Verification via WhatsApp — +971 54 548 8731
Test Overview & Methodology
The Cryptococcus Antibody Test is a specialized serum agglutination assay designed to detect host antibodies against Cryptococcus neoformans, an encapsulated yeast responsible for severe opportunistic infections — primarily cryptococcal meningitis and pulmonary cryptococcosis — in immunocompromised individuals. This assay provides complementary serological evidence that aids in the diagnosis of chronic or subacute cryptococcosis and supports epidemiological surveillance. Results must be interpreted alongside cryptococcal antigen testing, CSF analysis, and neuroimaging to establish a definitive clinical picture.
| Feature | Our Test — Cryptococcus Antibody (Agglutination) | Closest Alternative — Cryptococcal Antigen (CrAg) Test |
|---|---|---|
| Methodology | Standardized Latex Agglutination with Quantitative Titration | Lateral Flow Immunoassay (LFA) or Latex Agglutination for Antigen |
| Target Analyte | Host IgG/IgM Antibodies (immune response marker) | Cryptococcal Capsular Polysaccharide Antigen (direct pathogen detection) |
| Diagnostic Speed (TAT) | 2–3 Weeks (batch-processed send-out; sample by 7th of the month) | Same-Day to 48 Hours (rapid antigen detection) |
| Clinical Utility | Complementary serological evidence; aids chronic/subacute cryptococcosis diagnosis and epidemiological surveillance | First-line screening for active cryptococcal disease; CSF antigen is gold standard for meningitis |
| Price | 1800 AED | Variable (typically 400–900 AED depending on facility) |
Physician Insight & Safety Protocols
Dr. Ajay Singh, General Practitioner — DHA Registration ID: 36234132 — notes:
"The Cryptococcus Antibody Test provides useful adjunctive serological information when evaluating patients with suspected cryptococcal infection, particularly those with unexplained chronic headache, pulmonary infiltrates, or immunocompromised status. However, a negative antibody result does not exclude active disease, especially in severely immunosuppressed individuals who may mount a blunted humoral response. I always recommend interpreting this test alongside serum cryptococcal antigen, lumbar puncture with CSF analysis, and relevant neuroimaging."
"Timely referral to infectious disease or neurology specialists remains critical when clinical suspicion is high, regardless of antibody status."
Medication Advisory — Do Not Alter Prescribed Therapy
⚠ CRITICAL MEDICATION NOTICE:
Do not discontinue prescribed medication — including antifungals, corticosteroids, immunosuppressants, or antiretroviral therapy — without consulting your doctor. Abrupt cessation of antifungal agents or immunosuppressive drugs may precipitate rapid clinical deterioration, treatment resistance, or life-threatening immune reconstitution inflammatory syndrome (IRIS). Always consult your prescribing physician before making any changes to your medication regimen.
Patient Safety Advisory — Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Home Collection:
- Patient is a minor under 18 years of age without a legal guardian present (informed consent must be provided by a parent or legal guardian in accordance with UAE Federal Law No. 2 of 2019).
- Patient is unable to provide informed consent due to altered mental status, cognitive impairment, or acute neurological compromise.
- Known anaphylaxis to latex, chlorhexidine, or phlebotomy supplies — alternative collection arrangements must be made in a supervised clinical setting.
- Active seizure or acute meningeal signs at the time of scheduled collection — defer and escalate to emergency care immediately.
Emergency Red Flags — Seek Immediate Medical Attention:
- Severe headache with neck stiffness (meningismus) — potential cryptococcal meningitis requiring urgent CSF analysis.
- Altered mental status, confusion, or disorientation — may indicate raised intracranial pressure.
- Photophobia with fever and vomiting — classic meningeal irritation triad; do not delay emergency evaluation.
- New-onset seizures or focal neurological deficits — warrant immediate neuroimaging and hospitalization.
- Progressive dyspnea with pleuritic chest pain — may signal pulmonary cryptococcoma or acute respiratory compromise.
Patient FAQ & Clinical Guidance
1. What is the Cryptococcus Antibody Test used for, and who should consider it?
The Cryptococcus Antibody Test detects serum antibodies against Cryptococcus neoformans using latex agglutination methodology to diagnose cryptococcal infections in immunocompromised patients with neurological or respiratory symptoms. This test is primarily indicated for individuals with unexplained chronic meningitis, pulmonary nodules of unknown etiology, or those with compromised immunity — including HIV-positive patients, organ transplant recipients, and individuals on prolonged corticosteroid or biologic therapy. It is ordered by neurologists, pulmonologists, and general physicians when cryptococcal disease is suspected but antigen testing requires complementary serological evidence.
2. How should I prepare for the Cryptococcus Antibody Test, and what paperwork is required?
Fasting is not required but you must complete the mandatory Test Send Out Consent Form (Form 35) before sample collection, as this specimen is shipped to an international reference laboratory. A 2 mL serum sample (0.5 mL minimum) is collected via standard venipuncture into a Serum Separator Tube (SST) by our DHA-licensed phlebotomist during the home visit. The sample must be shipped refrigerated or frozen under strict cold-chain protocols. Please inform our team of all current medications — particularly antifungals, corticosteroids, immunosuppressants, and antiretroviral agents — as these influence antibody production and test interpretation. Ensure your referring physician has completed the test requisition with relevant clinical history for accurate laboratory correlation.
3. Why does the Cryptococcus Antibody Test take 2–3 weeks for results, and how will I receive them?
The Cryptococcus Antibody Test requires batch processing with samples collected by the 7th of each month followed by specialized agglutination analysis at an international reference laboratory, resulting in a 2–3 week turnaround time. This send-out methodology ensures the highest diagnostic accuracy through standardized reagent panels, quantitative titration, and rigorous quality control protocols that are not available with in-house rapid testing. Results are delivered via a secure, PDPL-compliant electronic portal with optional telephonic clinical guidance. Your referring physician will receive a comprehensive report including the antibody titer, reference range, and interpretive comments. If you require more rapid screening, please discuss same-day cryptococcal antigen (CrAg) testing with your doctor as a complementary option.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient data processing, storage, and transmission. All clinical data handled during the testing process is encrypted and processed within approved jurisdictions. The laboratory also adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields governing health information systems and digital health data. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that all specimen collection procedures, including mobile phlebotomy, meet the highest standards of patient safety and informed consent.
Clinical & Logistical Metadata
| Test Name | Cryptococcus Antibody Test (Latex Agglutination with Quantitative Titration) |
| Price (AED) | 1800 AED |
| Turnaround Time | 2–3 Weeks (batch-processed; samples collected by the 7th of each month) |
| Sample Type / Matrix | Serum (2 mL SST; 0.5 mL minimum) — VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM – 11 PM |
| Methodology Used | Standardized Latex Agglutination with Quantitative Titration |
| ICD-10-CM Code | B45.9 (primary), B45.0, B45.1 |
| LOINC Code | 23932-9 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians